B Reichart
Overview
Explore the profile of B Reichart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
453
Citations
2232
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oberhoffer M, Eifert S, Jaeger B, Blessing F, Beiras-Fernandez A, Seidel D, et al.
Surg J (N Y)
. 2017 Aug;
2(2):e5-e9.
PMID: 28824983
Early graft occlusion due to thromboembolic events is a well-known complication after coronary artery bypass grafting (CABG). Fibrinogen, the coagulation factor I, is a glycoprotein that is transformed by thrombin...
2.
Wolf-van Buerck L, Schuster M, Oduncu F, Baehr A, Mayr T, Guethoff S, et al.
Sci Rep
. 2017 Jun;
7(1):3572.
PMID: 28620237
Genetically engineered pigs are a promising source for islet cell transplantation in type 1 diabetes, but the strong human anti-pig immune response prevents its successful clinical application. Here we studied...
3.
Hubner T, Nickel T, Steinbeck G, Massberg S, Schramm R, Reichart B, et al.
Clin Res Cardiol
. 2015 Apr;
104(11):929-34.
PMID: 25841881
Aim: Currently, more than 900 patients with end-stage heart failure are listed for heart transplantation in Germany. All patients on the Eurotransplant high-urgent status (HU) have to be treated in...
4.
Reichart B, Niemann H, Chavakis T, Denner J, Jaeckel E, Ludwig B, et al.
Horm Metab Res
. 2014 Dec;
47(1):31-5.
PMID: 25506683
Solid organ and cell transplantation, including pancreatic islets constitute the treatment of choice for chronic terminal diseases. However, the clinical use of allogeneic transplantation is limited by the growing shortage...
5.
Beiras-Fernandez A, Kur F, Kaczmarek I, Frisch P, Weis M, Reichart B, et al.
Transplant Proc
. 2011 Aug;
43(6):2260-2.
PMID: 21839251
Background: Primary graft failure (PGF) is a severe complication responsible for 42% of the in-hospital mortality after heart transplantation. It has been postulated that once 30-day survival is achieved, patients...
6.
Beiras-Fernandez A, Angele M, Koutang C, Reichart B, Lohse P, Eifert S
Inflamm Res
. 2011 Feb;
60(5):439-45.
PMID: 21286777
Introduction: Progression of coronary artery disease (CAD) after primary coronary artery bypass grafting (CABG) is frequent and may lead to recurrent symptoms. Various data indicate that apoptosis is the main...
7.
Labarrere C, Woods J, Hardin J, Campana G, Ortiz M, Jaeger B, et al.
Am J Transplant
. 2011 Jan;
11(3):528-35.
PMID: 21219580
Early risk-prediction is essential to prevent cardiac allograft vasculopathy (CAV) and graft failure in heart transplant patients. We developed multivariate models to identify patients likely to experience CAV, severe CAV,...
8.
Walther S, Beiras-Fernandez A, Csapo C, Munzing S, Stief C, Hammer C, et al.
Transplant Proc
. 2010 Jul;
42(5):1931-4.
PMID: 20620550
Objectives: Polyclonal antithymocyte globulins (ATGs) are immunosuppressive agents applied for the treatment and prevention of organ rejection after transplantation. ATGs induce complement-mediated cell death in T lymphocytes and decrease leukocyte...
9.
Beiras-Fernandez A, Kur F, Kiefer S, Sodian R, Schmoeckel M, Weis M, et al.
Transplant Proc
. 2009 Sep;
41(6):2589-91.
PMID: 19715980
Objectives: The rate of infection in patients who require ventricular assist devices (VADs) is estimated at more than 35%. Infections with multidrug-resistant (MDR) organisms in VAD recipients present a high...
10.
Beiras-Fernandez A, Walther S, Csapo C, Muenzing S, Hammer C, Reichart B, et al.
Transplant Proc
. 2009 Sep;
41(6):2286-8.
PMID: 19715899
Objective: Polyclonal antithymocyte globulins (ATGs) are immunosuppressive agents used for the treatment of organ rejection after transplantation. ATGs induce complement-mediated cell death of T lymphocytes and may decrease leukocyte adhesion....